How does one assess early rheumatoid arthritis in daily clinical practice?

被引：68

作者：

van Riel, PLCM ^{[1
]}

Schumacher, HR ^{[1
]}

机构：

[1] Univ Med Ctr Nijmegen, Dept Rheumatol, NL-6525 GA Nijmegen, Netherlands

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2001年 / 15卷 / 01期

关键词：

rheumatoid arthritis; assessment; daily clinical practice; prognostic factors; disease activity score;

D O I：

10.1053/berh.2000.0126

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In past years, consensus has been reached on the assessment of rheumatoid arthritis in clinical trials. Next to a core set of disease activity variables, response criteria have been developed and validated. These criteria are, however, of limited valve in daily clinical practice. In this situation, emphasis should be paid to accurate measurement of disease activity on a continuous scale using the lowest possible number of core set variables. Different studies have shown that the DAS28 is a valuable instrument for this purpose. Many factors have been identified to possess a prognostic value; however. the IgM rheumatoid factor is still the only one which is of any importance in daily clinical practice.

引用

页码：67 / 76

页数：10

共 65 条

[21]

Hayem G, 1999, J RHEUMATOL, V26, P7

[22] Early aggressive DMARD therapy: The key to slowing disease progression in rheumatoid arthritis [J].

Hochberg, MC .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1999, 28 :3-7

[23]

Klimiuk PA, 1997, AM J PATHOL, V151, P1311

[24]

KROOT EJA, 2000, IN PRESS ARTHRITIS R

[25] Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis [J].

Levin, RW ;

Park, J ;

Ostrov, B ;

Reginato, A ;

Baker, DG ;

Bomalaski, JS ;

Borofsky, M ;

Gardiner, M ;

Leventhal, L ;

Louthrenoo, W ;

vonFeldt, J ;

Kolasinski, S ;

Schumacher, HR .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, 25 (05) :277-281

[26] THE RAPID ASSESSMENT OF DISEASE-ACTIVITY IN RHEUMATOLOGY (RADAR) QUESTIONNAIRE - VALIDITY AND SENSITIVITY TO CHANGE OF A PATIENT SELF-REPORT MEASURE OF JOINT COUNT AND CLINICAL STATUS [J].

MASON, JH ;

ANDERSON, JJ ;

MEENAN, RF ;

HARALSON, KM ;

LEWISSTEVENS, D ;

KAINE, JL .

ARTHRITIS AND RHEUMATISM, 1992, 35 (02) :156-162

[27] SAFETY AND EFFECTIVENESS OF LEFLUNOMIDE IN THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, PHASE-II STUDY [J].

MLADENOVIC, V ;

DOMLJAN, Z ;

ROZMAN, B ;

JAJIC, I ;

MIHAJLOVIC, D ;

DORDEVIC, J ;

POPOVIC, M ;

DIMITRIJEVIC, M ;

ZIVKOVIC, M ;

CAMPION, G ;

MUSIKIC, P ;

LOWFRIEDRICH, I ;

OED, C ;

SEIFERT, H ;

STRAND, V .

ARTHRITIS AND RHEUMATISM, 1995, 38 (11) :1595-1603

[28] Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein [J].

Moreland, LW ;

Baumgartner, SW ;

Schiff, MH ;

Tindall, EA ;

Fleischmann, RM ;

Weaver, AL ;

Ettlinger, RE ;

Cohen, S ;

Koopman, WJ ;

Mohler, K ;

Widmer, MB ;

Blosch, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :141-147

[29]

MOTTONEN TT, PREDICTION EROSIVENE

[30]

Mustila A, 2000, ARTHRITIS RHEUM-US, V43, P1371, DOI 10.1002/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO

← 1 2 3 4 5 6 7 →